Opens in a new tab

Advanced Bionics v MED-EL Elektromedizinische Geräte Gesellschaft m.b.H. (CoA, ORD_42779/2024, 5 September 2024)

Date5 September 2024
CourtCoA
DivisionLuxembourg (LU)
Type of actionAppeal RoP220.1
Registry referenceAPL_24598/2024 · ORD_42779/2024
PartiesAdvanced Bionics GmbH, Advanced Bionics Sarl , Advanced Bionics AG v. MED-EL Elektromedizinische Geräte Gesellschaft m.b.H.

Official decision (PDF) · UPC registry entry

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 10 October 2026

Our analysis

Summary

By order of 5 September 2024 (UPC_CoA_207/2024, APL_24598/2024), the Court of Appeal dismissed Advanced Bionics’ appeal against the order of the President of the Court of First Instance of 15 April 2024, which had refused to replace German with English, the language of EP 4 074 373, in the infringement action brought by MED-EL before the Mannheim Local Division. The fact that the parties are based in countries where the claimant’s chosen language is an official language is an important factor (paragraph 12). The order adds that a request to change the language may be made before the statement of defence (paragraph 20).

Question

Did the President misapply Art. 49(5) UPCA by refusing a change to English, when the language of the patent and of the parallel revocation action before the Central Division was English?

Decision

No. The President has a discretion based on fairness and all relevant circumstances, in particular the defendant’s position (paragraph 9), applying the principles set out in Curio Bioscience v 10x Genomics (paragraph 11). The defendants are based in German- or French-speaking countries (paragraph 12), Advanced Bionics is a multinational group with a large patent department, whereas MED-EL, much smaller, has no legal department (paragraph 13). A change would require translations or bilingual proceedings (paragraph 14). The use of English in the technical field does not outweigh where the parties are established (paragraph 16), and MED-EL’s earlier language choices do not by themselves require a change (paragraph 17). The admissibility objection did not need deciding. Rule 323.3 RoP does not prevent the request being made before the statement of defence, and early filing is preferable (paragraphs 19 and 20).

Key points for practice

Provisions applied

Agreement on a Unified Patent Court
Art. 49(5)
Rules of Procedure
Rules 323 and 323.3
Case law cited
Curio Bioscience v 10x Genomics, Court of Appeal, 17 April 2024.

Related decisions

Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Going further

Lexicon: UPC Court of Appeal, Supplementary protection certificate (SPC), Biosimilar medicinal product, Launch at risk.

Dhenne Avocats blog: UPC Appeals: What the Numbers Show, Pharmaceutical patents and the UPC: is the Court hostile to them?.

Publications by Matthieu Dhenne: The Launch Letter: How Generics and Biosimilars Should Write to Avoid UPC Urgency (Kluwer Patent Blog).

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
not recorded
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

No case number recorded in this record.

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

No other decision in the corpus bears the same case number, and no appeal is documented in the corpus to date.

What the record states

Nature of the act
Appeal RoP220.1
Outcome (Dhenne Avocats summary)
La cour d'appel confirme le maintien de l'allemand : le siège des parties dans des pays germanophones et la disproportion de leurs moyens l'emportent sur l'usage de l'anglais.
Appeal
Decision of the Court of Appeal.
Instance
Court of Appeal decision.

Patents mentioned

Related decisions cited in the analyses

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

PublicationRole in the disputeFamilyStandard and declarationPoolSources
EP 4 074 373
Mri-safe disk magnet for implants
recorded proprietor: MED EL Elektromedizinische Geraete GmbH
Mentioned in the analysis (role not qualified)
Also mentioned in 9 other decision(s): Advanced Bionics v MED-EL Elektromedizinische Geräte (CFI, 26 December · MED-EL Elektromedizinische Geräte v Zhejiang Nurotron Biotechnology (C · MED-EL Elektromedizinische Geräte v Zhejiang Nurotron Biotechnology (C · Advanced Bionics v MED-EL Elektromedizinische Geräte (CoA, 3 July 2025 · MED-EL v Advanced Bionics (CFI, 28 May 2025) · Advanced Bionics v MED-EL Elektromedizinische Geräte Gesellschaft m.b. · MED-EL Elektromedizinische Geräte Gesellschaft m.b.H. v Advanced Bioni · Advanced Bionics v MED-EL Elektromedizinische Geräte (CFI, 15 April 20
not recordednot recordednot recordedEspacenet · European Patent Register
existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically)
mentioned in: Dhenne Avocats analysis
The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.